Forte Biosciences Inc. (FBRX)
AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
16.64
2.02 (13.82%)
At close: Jan 15, 2025, 3:59 PM
16.50
-0.84%
After-hours Jan 15, 2025, 04:00 PM EST
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 |
Net Income | -31.48M | -13.88M | -21.71M | -46.49M | -4.07M | -48.95M | -38.93M | -33.48M | -23.06M |
Depreciation & Amortization | 9.00K | n/a | 36.00K | 54.00K | 11.00K | 625.00K | 292.00K | 255.00K | 232.00K |
Stock-Based Compensation | 3.28M | 4.01M | 4.21M | 956.00K | 35.71K | 6.87M | 4.45M | n/a | n/a |
Other Working Capital | -663.00K | 1.47M | 1.01M | -3.46M | 274.84K | 4.82M | 2.21M | 1.28M | 176.00K |
Other Non-Cash Items | -131.00K | 3.81M | 61.00K | 30.89M | -918.00K | 7.77M | 5.26M | 1.74M | 928.00K |
Deferred Income Tax | n/a | n/a | n/a | n/a | 918.00K | -6.87M | -4.45M | n/a | n/a |
Change in Working Capital | -392.00K | 1.68M | 720.00K | -3.83M | 1.25M | 6.08M | 2.52M | 1.87M | 747.00K |
Operating Cash Flow | -28.71M | -8.19M | -16.68M | -18.42M | -2.77M | -34.47M | -31.13M | -29.54M | -21.04M |
Capital Expenditures | -88.00K | n/a | n/a | n/a | -161.60K | -1.97M | -655.00K | -525.00K | -231.00K |
Acquisitions | n/a | n/a | n/a | 3.58K | n/a | 2.22M | 20.00K | n/a | 15.00K |
Purchase of Investments | -9.96M | n/a | n/a | n/a | n/a | -70.75M | -70.80M | -23.00M | -59.87M |
Sales Maturities Of Investments | 10.10M | n/a | n/a | n/a | n/a | 68.52M | 43.73M | 48.09M | 35.16M |
Other Investing Acitivies | n/a | n/a | n/a | 3.58M | 42.32M | -2.22M | -27.05M | 25.09M | -24.70M |
Investing Cash Flow | 47.00K | n/a | n/a | 3.58M | -161.60K | -4.19M | -27.71M | 24.57M | -24.93M |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | 23.32M | 138.00K | 2.91M | 50.74M |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | 89.00K | 3.38M | 33.23M |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | -28.00K | 12.00K | -44.00K | -32.00K | 4.86M | -8.63M | n/a | -592.00K | -982.00K |
Financial Cash Flow | 24.68M | 7.24M | -44.00K | 66.67M | 4.86M | 43.54M | 89.26M | 2.33M | 49.92M |
Net Cash Flow | -3.98M | -944.00K | -16.72M | 51.83M | 1.92M | 4.88M | 30.42M | -2.64M | 3.95M |
Free Cash Flow | -28.79M | -8.19M | -16.68M | -18.42M | -2.93M | -36.44M | -31.79M | -30.06M | -21.27M |